학력

• 1986-1990 전남대학교 약학사
• 1990-1992 전남대학교 약학 석사
• 1992-1996 전남대학교 약학 박사

경력

• 2000-2002: BK21 Research Professor, Chosun University
• 2002-2003: Research professor, Chonnam National University
• 2007-2009: Research fellow & Staff Research Scientist, Dept. of Medicine, University of California San Diego

연구분야

• TLR-targeted vaccine adjuvant development
• Cancer immunotherapy
• Searching for targets of new paradigm anti-microbial therapeutic modalities

주요논문

• Nguyen TD, Le DH, Dang CG, Jung HS, Choi Y, Khim K, Kim Y, Lee SE*, Rhee JH*. A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model. Nature Communications 2025 Mar 24;16(1):2871. doi: 10.1038/s41467-025-58115-8.PMID: 40128220
• Thiruppathi J, Vijayan V, Hwang HS, Bang YJ, Loeurng V, Hong SH, Sundaram A, Park I-K, Lee SE*, Rhee JH*. Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment. Journal for Immunotherapy of Cancer 2025 Mar 21; 13(3):e010272. Doi: 10.1136/jitc-2024-010272. PMID: 40118497.
• Tan W, Thiruppathi J, Hong SH, Puth S, Pheng S, Mun B-R, Choi W-S, Lee K-H, Park H-S, Nguyen TD, Lee M-C, Jeong K, Zheng JH, Kim Y, Lee SE*, Rhee JH*. Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers. NPJ Vaccines 2024 Jun. 15; 9:108. doi.org/10.1038/s41541-024-00904-1.
• Puth S, Verma V, Hong SH, Tan W, Lee SE*, Rhee JH*. An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation. Biomaterials 2022 Jul; 286: 121542.
• Lee SE*, Li X, Kim JC, Lee J, Gonzalez-Navajas JM, Hong SH, Park I-K, Rhee JH, Raz E*. Type I Interferons Maintain Foxp3 Expression and T-Regulatory Cell Functions under Inflammatory Conditions in Mice. Gastroenterology 2012. Jul. 143(1): 145-154. Featured by Han-vit-sa, BRIC, Apr. 2012. 外 다수